Delivery Order SPE2DR25D3201-SPE2DR26FT5RL
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,304.62 by the Defense Logistics Agency (DLA) on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract involves the delivery of Lumason 25 mg vials and is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement action under DLA's broader...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,881.93 by the Defense Logistics Agency for Lumason 25 mg vials. The contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed-price pricing and was competitively awarded with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $1,493.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumason 25 mg vials, with an ultimate completion date of June 2, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The contract will be fulfilled from the vendor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lumason 25 mg vials, with a ceiling value of $1,190.24 and a firm fixed price structure. This competitively awarded, non-set-aside contract is classified as a delivery order with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under a larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,949.88 on December 31, 2025, for the supply of LUMASON 25 mg vials, with completion scheduled for January 2, 2026. This is a firm fixed price contract with no set-aside designation, executed through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,407.76 delivery order to AmerisourceBergen Drug Corp for Lumason 25 mg vials on January 16, 2026, with completion scheduled for January 20, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lumason is a contrast-enhancing pharmaceutical used in diagnostic ultrasound imaging across various clinical applications. AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,740.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumason 25 mg vials, with an ultimate completion date of January 7, 2026. This non-set-aside contract was competitively awarded on January 6, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in supplying critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $126,956.16 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. The competitively awarded, firm fixed-price contract with an ultimate completion date of January 20, 2026 represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. This prime indefinite delivery vehicle,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,067.10 on January 22, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, which is firm fixed-price and carries an ultimate completion date of January 23, 2026, represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,666.14 by the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The parent...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5RLDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,450.40 by the Defense Logistics Agency (DLA) on January 27, 2026, for the supply of Lumason 25 mg vials. The contract is firm fixed-price with no set-aside designation, indicating competitive award based on open competition. Performance is scheduled for completion by January 28, 2026, at the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a task order execution under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen Corporation), which serves as the parent organization and holds the primary indefinite delivery contract with DLA. The company functions as a critical vendor for federal medical procurement, supplying a broad range of pharmaceutical products to military healthcare systems, the Defense Health Agency, and other government medical institutions. Through its competitive positioning and established contract vehicles with DLA, AmerisourceBergen maintains significant capability to fulfill federal pharmaceutical supply requirements across multiple therapeutic domains and customer bases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/26/26 |